SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $3,265,000 | -63.9% | 245,866 | -60.6% | 0.09% | -64.8% |
| Q4 2014 | $9,037,000 | -32.0% | 624,512 | -0.9% | 0.26% | -35.8% |
| Q3 2014 | $13,299,000 | -29.2% | 630,282 | -0.1% | 0.41% | -25.0% |
| Q2 2014 | $18,790,000 | +21.6% | 630,764 | -1.9% | 0.55% | +31.7% |
| Q1 2014 | $15,450,000 | +40.9% | 642,934 | +19.4% | 0.42% | +47.5% |
| Q4 2013 | $10,969,000 | -32.3% | 538,504 | +56.9% | 0.28% | -34.6% |
| Q3 2013 | $16,207,000 | +22.8% | 343,160 | -1.1% | 0.43% | +13.4% |
| Q2 2013 | $13,193,000 | – | 346,840 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |